- Clinical Essentials from HIV Med
- 1 comment
Data from a Dutch nationwide prospective study.
Meta-analysis of 10 randomized controlled trials by Early Breast Cancer Trialists’ Collaborative Group.
Evidence for 5-year effectiveness and safety.
WSG-ADAPT-TN randomized trial reveals higher pCR rate and fewer adverse events.
There may be increased susceptibility at later age.
One exception is urgent surgery.
Hemophilia-related mortality less likely related to cardiac complications and cancer.
CPR international consensus recommendations | A call for newborn CHD screening | ACC decision pathway for bleeding management with anticoagulants.
Adding pazopanib to paclitaxel boosts toxicity, but not survival.
Drug showed significant improvement in time to normalization of platelet count.
Carboplatin is the preferred treatment, but thromboembolism risk was understudied.
Data from over 141K individuals in 2 prospective cohorts show no association.
An observational cohort study of a care model used in the Netherlands.
It’s as effective as face-to-face training, and both are better than usual care.
The drugs performed similarly in a Danish registry study.